OraSure Technologies | OSUR - Ebitda


OraSure Technologies reported $-17.7M in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
Agilent USD 456M 84M Dec/2025
AngioDynamics USD 5.94M 3.78M Sep/2025
Becton, Dickinson and Co. USD 1.71B 1B Jun/2026
Bio Techne USD 115.94M 763K Jun/2026
Bio-Rad Laboratories USD 595.3M 1.23B Jun/2026
Bruker USD 143.2M 33.2M Jun/2026
Charles River Laboratories USD 272.95M 43.14M Jun/2026
Danaher USD 1.84B 81M Jun/2026
Dentsply International USD 190M 61M Jun/2026
Dexcom USD 364.5M 57.7M Mar/2026
Illumina USD 330M 80M Jun/2026
Integra LifeSciences USD 78.41M 2.23M Jun/2026
Intuitive Surgical USD 1.06B 29.9M Mar/2026
IQVIA Holdings USD 994M 62M Jun/2026
Mesa Laboratories USD 9.58M 1.47M Sep/2024
Mettler Toledo International USD 322.64M 43.66M Jun/2026
Myriad Genetics USD 14.3M 4M Dec/2025
OraSure Technologies USD -17.7M 4.06M Dec/2025
Quidel USD 129.3M 20.6M Jun/2026
Repligen USD 43.77M 3.76M Jun/2026
Revvity USD 228.18M 44.73M Jun/2026
STAAR Surgical USD 20M 387K Jun/2026
Thermo Fisher Scientific USD 3.55B 845M Jun/2026
Trinity Biotech USD -9.6M 7.64M Dec/2024
Waters USD 712M 545M Jun/2026